ID: ALA14837

Max Phase: Preclinical

Molecular Formula: C10H11ClN2O3

Molecular Weight: 206.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.Oc1ccc(C(O)c2ncc[nH]2)cc1O

Standard InChI:  InChI=1S/C10H10N2O3.ClH/c13-7-2-1-6(5-8(7)14)9(15)10-11-3-4-12-10;/h1-5,9,13-15H,(H,11,12);1H

Standard InChI Key:  HLWGCXFNOIPUAN-UHFFFAOYSA-N

Associated Targets(Human)

Homo sapiens 32628 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin (5-HT) receptor 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 206.20Molecular Weight (Monoisotopic): 206.0691AlogP: 0.90#Rotatable Bonds: 2
Polar Surface Area: 89.37Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.20CX Basic pKa: 5.76CX LogP: 0.49CX LogD: 0.47
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.55Np Likeness Score: 0.30

References

1. Miller DD, Hamada A, Clark MT, Adejare A, Patil PN, Shams G, Romstedt KJ, Kim SU, Intrasuksri U, McKenzie JL..  (1990)  Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human platelets.,  33  (4): [PMID:2157007] [10.1021/jm00166a009]

Source